Robyn M. Teply, PharmD, MBA, BCACP, associate professor in the Department of Pharmacy Practice in the School of Pharmacy and Health Professions published a project with colleagues from Temple University, University of Illinois at Chicago and Vanderbilt University, “Expanding Hepatitis C Virus Care and Cure; National Experience Using a Clinical Pharmacist-Driven Model” in the Open Forum Infectious Diseases.
The U.S. National Viral Hepatitis Action Plan depends on additional providers to expand hepatitis C virus (HCV) treatment capacity in order to achieve elimination goals. Clinical pharmacists manage treatment and medication within interdisciplinary teams. The study’s objective was to determine sustained virologic response (SVR) rates for clinical pharmacist–delivered HCV therapy in an open medical system.
To learn more this project please visit here.
